openPR Logo
Press release

CD BioSciences Accelerates Drug Discovery & Development with Cutting-Edge Imaging Analysis Solutions

12-16-2024 07:58 PM CET | Health & Medicine

Press release from: ABNewswire

CD BioSciences Accelerates Drug Discovery & Development with

CD BioSciences introduces Imaging Analysis services for the scientific community.
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, has recently introduced a new range of Imaging Analysis [https://www.bioimagingtech.com/imaging-analysis-for-drug-discovery-development.html] services for the scientific community to accelerate their drug discovery and development, including the Drug Targets Imaging Analysis, the In Vivo Drug Delivery Imaging Monitoring, the Imaging Monitoring of Biomarkers in Tissues, and the Drug Toxicity Imaging Analysis.

Drug discovery is an interdisciplinary field that focuses on the in vitro, ex vivo and in vivo identification and preclinical testing of drug candidates. The drug development process itself is typically divided into two distinct yet interconnected phases, research and development. These stages follow a sequential order, with the research phase preceding the identification of candidate drugs. Once candidate drugs are selected, the development phase commences. In recent years, the integration of imaging technology has revolutionized drug research and development, significantly advancing the medical field.

In recent decades, high-resolution electron microscopy has made it possible to study the structure of drug targets, helping researchers to design synthetically relevant drug candidates. In addition, a lack of clarity about the cellular signalling pathways involved in drug action can lead to unmeasured side effects and slow down drug development. Cellular imaging can help to analyze the underlying mechanisms. Thus, molecular imaging plays an important role in drug discovery.

CD BioSciences has been developing imaging technologies for many years and boasts a team of experienced researchers specializing in imaging analysis. The company can provide clients with imaging services for drug discovery and development, including imaging of drug targets, imaging of biomarkers in tissues, imaging of toxicity and in vivo imaging of drug efficacy. These imaging analysis services can not only provide an important theoretical basis for drug discovery and development, but also reduce the associated costs and streamline the development timeline.

For example, CD BioSciences offers Drug Toxicity Imaging Analysis services throughout the drug development process, including hepatotoxicity imaging, liver fibrosis imaging, mitochondrial function imaging, cardiotoxicity imaging, and nephrotoxicity imaging. Its experienced team utilizes high-content imaging systems to analyze multiple drug toxicity parameters concurrently, generating high-quality data efficiently and cost-effectively. Unlike conventional in vitro toxicity testing with limited insights, high-content screening can simultaneously monitor and analyze multiple indicators of drug toxicity, such as cell number, survival, apoptosis, calcium ion levels, and mitochondrial membrane potential, offering a more comprehensive assessment of drug toxicity.

CD BioSciences has been engaged in the development of imaging technology for many years. The company can design personalized imaging analysis plans based on the client's needs and provide accurate and reproducible experimental data. To find out more about the new Imaging Analysis services, please visit https://www.bioimagingtech.com/imaging-analysis-for-drug-discovery-development.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-accelerates-drug-discovery-development-with-cuttingedge-imaging-analysis-solutions]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD BioSciences Accelerates Drug Discovery & Development with Cutting-Edge Imaging Analysis Solutions here

News-ID: 3789361 • Views:

More Releases from ABNewswire

Leavitt Peak Press Announces the Release of the Guardians: Paporia Two by F. Thomas Jones - A Bold New Chapter in an Epic Interstellar Saga
Leavitt Peak Press Announces the Release of the Guardians: Paporia Two by F. Tho …
Leavitt Peak Press is proud to announce the release of The Guardians: Paporia Two, the action-packed sequel to The Guardians: Escape from Tirgonia by military veteran and author F. Thomas Jones. This thrilling continuation of the Guardians saga dives deeper into a galactic conflict that pits courage, loyalty, and wisdom against overwhelming odds. Now in the second year of war with the ruthless Tirogian Empire, The Guardians face their greatest challenge
Jiaropack Expands Global Footprint and U.S. Manufacturing to Strengthen Supply Chain and Delivery Network
Jiaropack Expands Global Footprint and U.S. Manufacturing to Strengthen Supply C …
Image: https://www.abnewswire.com/upload/2025/10/e8885cfe8ab28873224866f01a36a3fa.jpg California, USA - Jiaropack, a brand of Global Store Supply, Inc., a global leader in packaging, industrial, and shipping materials, today announced a major expansion of its U.S. manufacturing and logistics network to further enhance supply chain stability and nationwide delivery efficiency, providing faster and more reliable products and services to customers worldwide. To enhance supply chain security and consistent product delivery, Jiaropack has recently purchased several Texas-based plastic product
Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million in 2024 and It is expected to increase by 2034, estimates DelveInsight
Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million i …
DelveInsight's "Clostridioides Difficile Infection Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Clostridioides Difficile Infection, historical and forecasted epidemiology as well as the Clostridioides Difficile Infection therapeutics market trends in the US, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover Key Insights into the Clostridioides Difficile Infection Market with DelveInsight's In-Depth Report @ Clostridioides Difficile Infection Treatment Market Size
Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovative therapies and rising incidence drive steady expansion across the US, Europe, and Japan
Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovativ …
Driven by rise of immunotherapies, antibody-drug conjugates, and precision-targeted approaches, TNBC market is projected to expand from USD 4.7 billion in 2025 to USD 7.1 billion by 2034, marking a CAGR of 4.7% across the 7MM. Leading players like AstraZeneca, Pfizer, Gilead Sciences, BioNTech, Astellas Pharma are at forefront, advancing next-generation therapies such as ADC platforms, checkpoint inhibitors, and novel vaccines that aim to improve survival outcomes and redefine patient

All 5 Releases


More Releases for BioSciences

Nanostructured Drug Market Poised for Growth with Advancements in Targeted Deliv …
Nanostructured Drug Market Overview Nanostructured Drug Market is projected to grow significantly during the forecast period, driven by advancements in nanotechnology and increasing demand for targeted drug delivery systems. The latest report (2025-2032) on the Nanostructured Drug Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also
CRISPR-Based Diagnostics Market for Infectious Diseases & Cancer Detection By 20 …
Global CRISPR-Based Diagnostics Market reached at a CAGR during the forecast period 2024-2031. Crispr-Based Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate
CRISPR-Based Diagnostics Market: Global Type, Trends, Service, Growth, Opportuni …
The CRISPR-Based Diagnostics Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/crispr-based-diagnostics-market What is the projected
CRISPR Based Diagnostics Market Growing Rapidly by 2031 - Sherlock Biosciences, …
DataM Intelligence has published a new research report on "CRISPR Based Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research PDF
Glycated Albumin Market to See Booming Growth 2024-2031 | Lifespan Biosciences, …
Glycated Albumin Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Glycated Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycated Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful
Congenital Adrenal Hyperplasia Market to Witness Growth by 2032, Estimates Delve …
DelveInsight's "Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Congenital Adrenal Hyperplasia, historical and forecasted epidemiology as well as the Congenital Adrenal Hyperplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Congenital Adrenal Hyperplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here: https://www.delveinsight.com/sample-request/congenital-adrenal-hyperplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of